• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无毒李斯特菌 Dps 作为基于生物发光的光动力治疗的纳米平台,利用 Gaussia princeps 荧光素酶和锌原卟啉 IX。

Listeria innocua Dps as a nanoplatform for bioluminescence based photodynamic therapy utilizing Gaussia princeps luciferase and zinc protoporphyrin IX.

机构信息

Centre for Biomolecular Sciences, School of Chemistry, The University of Nottingham, Nottingham, UK.

School of Physics & Astronomy, The University of Nottingham, University Park, Nottingham, UK; and School of Chemistry, University of Lincoln, UK.

出版信息

Nanomedicine. 2019 Aug;20:102005. doi: 10.1016/j.nano.2019.04.008. Epub 2019 Apr 29.

DOI:10.1016/j.nano.2019.04.008
PMID:31048084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6712498/
Abstract

Listeria innocua DNA binding protein from starved cells (LiDps) belongs to the ferritin family and provides a promising self-assembling spherical 12-mer protein scaffold for the generation of functional nanomaterials. We report the creation of a Gaussia princeps luciferase (Gluc)-LiDps fusion protein, with chemical conjugation of Zinc (II)-protoporphyrin IX (ZnPP) to lysine residues on the fusion protein (giving Gluc-LiDps-ZnPP). The Gluc-LiDps-ZnPP conjugate is shown to generate reactive oxygen species (ROS) via Bioluminescence Resonance Energy Transfer (BRET) between the Gluc (470-490 nm) and ZnPP. In vitro, Gluc-LiDps-ZnPP is efficiently taken up by tumorigenic cells (SKBR3 and MDA-MB-231 breast cancer cells). In the presence of coelenterazine, this construct inhibits the proliferation of SKBR3 due to elevated ROS levels. Following exposure to Gluc-LiDps-ZnPP, migration of surviving SKBR3 cells is significantly suppressed. These results demonstrate the potential of the Gluc-LiDps-ZnPP conjugate as a platform for future development of an anticancer photodynamic therapy agent.

摘要

来自饥饿细胞的无害李斯特菌 DNA 结合蛋白(LiDps)属于铁蛋白家族,为功能性纳米材料的生成提供了一种有前途的自组装的 12 聚体球形蛋白支架。我们报告了一种海肾荧光素酶(Gluc)-LiDps 融合蛋白的创建,该蛋白通过赖氨酸残基上的化学缀合锌(II)原卟啉 IX(ZnPP)(产生 Gluc-LiDps-ZnPP)。Gluc-LiDps-ZnPP 缀合物通过 Gluc(470-490nm)和 ZnPP 之间的生物发光共振能量转移(BRET)产生活性氧物种(ROS)。在体外,Gluc-LiDps-ZnPP 被肿瘤细胞(SKBR3 和 MDA-MB-231 乳腺癌细胞)有效摄取。在 coelenterazine 的存在下,由于 ROS 水平升高,该构建物抑制 SKBR3 的增殖。暴露于 Gluc-LiDps-ZnPP 后,存活的 SKBR3 细胞的迁移明显受到抑制。这些结果表明,Gluc-LiDps-ZnPP 缀合物作为未来开发抗癌光动力治疗剂的平台具有潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d094/6712498/b16e64c4082d/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d094/6712498/9b9cb18c63eb/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d094/6712498/636c53560d4b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d094/6712498/32fc9f8e8143/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d094/6712498/28a102a846e4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d094/6712498/4520eb35f536/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d094/6712498/8495b17a3bf7/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d094/6712498/b16e64c4082d/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d094/6712498/9b9cb18c63eb/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d094/6712498/636c53560d4b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d094/6712498/32fc9f8e8143/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d094/6712498/28a102a846e4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d094/6712498/4520eb35f536/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d094/6712498/8495b17a3bf7/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d094/6712498/b16e64c4082d/gr6.jpg

相似文献

1
Listeria innocua Dps as a nanoplatform for bioluminescence based photodynamic therapy utilizing Gaussia princeps luciferase and zinc protoporphyrin IX.无毒李斯特菌 Dps 作为基于生物发光的光动力治疗的纳米平台,利用 Gaussia princeps 荧光素酶和锌原卟啉 IX。
Nanomedicine. 2019 Aug;20:102005. doi: 10.1016/j.nano.2019.04.008. Epub 2019 Apr 29.
2
The so-called Listeria innocua ferritin is a Dps protein. Iron incorporation, detoxification, and DNA protection properties.所谓的无害李斯特菌铁蛋白是一种Dps蛋白。具有铁掺入、解毒和DNA保护特性。
Biochemistry. 2005 Apr 19;44(15):5572-8. doi: 10.1021/bi0472705.
3
Synthesis of iron oxide nanoparticles in Listeria innocua Dps (DNA-binding protein from starved cells): a study with the wild-type protein and a catalytic centre mutant.在李斯特菌 Dps(饥饿细胞中的 DNA 结合蛋白)中合成氧化铁纳米颗粒:野生型蛋白和催化中心突变体的研究。
Chemistry. 2010 Jan 11;16(2):709-17. doi: 10.1002/chem.200901138.
4
Cell-free production of Gaussia princeps luciferase--antibody fragment bioconjugates for ex vivo detection of tumor cells.用于离体检测肿瘤细胞的海肾荧光素酶-抗体片段生物共轭物的无细胞生产
Biochem Biophys Res Commun. 2009 Dec 18;390(3):971-6. doi: 10.1016/j.bbrc.2009.10.087. Epub 2009 Oct 21.
5
Gaussia princeps luciferase: a bioluminescent substrate for oxidative protein folding.海肾萤光素酶:一种用于氧化蛋白折叠的生物发光底物。
Protein Sci. 2018 Aug;27(8):1509-1517. doi: 10.1002/pro.3433. Epub 2018 Jul 18.
6
Advanced Bioluminescence Reporter with Engineered Luciferase via Sequence-Guided Mutagenesis.通过序列引导的诱变工程化荧光素酶的高级生物发光报告基因。
Biosensors (Basel). 2024 Nov 1;14(11):528. doi: 10.3390/bios14110528.
7
Biophysical characterization of highly active recombinant Gaussia luciferase expressed in Escherichia coli.在大肠杆菌中表达的高活性重组高斯荧光素酶的生物物理特性
Biochim Biophys Acta. 2010 Sep;1804(9):1902-7. doi: 10.1016/j.bbapap.2010.04.014. Epub 2010 May 7.
8
Optimization of enzyme-substrate pairing for bioluminescence imaging of gene transfer using Renilla and Gaussia luciferases.优化酶-底物配对,提高 Renilla 和 Gaussia 荧光素酶用于基因转染的生物发光成像效果。
J Gene Med. 2010 Jun;12(6):528-37. doi: 10.1002/jgm.1463.
9
Alternative luciferase for monitoring bacterial cells under adverse conditions.用于在不利条件下监测细菌细胞的替代性荧光素酶。
Appl Environ Microbiol. 2005 Jul;71(7):3427-32. doi: 10.1128/AEM.71.7.3427-3432.2005.
10
Molecular Dynamics Simulation Combined with Neural Relationship Inference and Markov Model to Reveal the Relationship between Conformational Regulation and Bioluminescence Properties of Luciferase.分子动力学模拟结合神经关系推断和马尔可夫模型揭示荧光素酶构象调节与生物发光性质的关系。
Molecules. 2024 Aug 26;29(17):4029. doi: 10.3390/molecules29174029.

引用本文的文献

1
Bioluminescent Systems for Theranostic Applications.用于治疗应用的生物发光系统。
Int J Mol Sci. 2024 Jul 10;25(14):7563. doi: 10.3390/ijms25147563.
2
A Comprehensive Exploration of Bioluminescence Systems, Mechanisms, and Advanced Assays for Versatile Applications.生物发光系统、机制及多功能应用的先进检测方法的全面探索
Biochem Res Int. 2024 Feb 5;2024:8273237. doi: 10.1155/2024/8273237. eCollection 2024.
3
System for Self-excited Targeted Photodynamic Therapy Based on the Multimodal Protein DARP-NanoLuc-SOPP3.基于多模态蛋白DARP-NanoLuc-SOPP3的自激发靶向光动力治疗系统

本文引用的文献

1
Luciferase-Rose Bengal conjugates for singlet oxygen generation by bioluminescence resonance energy transfer.通过生物发光共振能量转移产生单线态氧的荧光素酶-孟加拉玫瑰红缀合物
Chem Commun (Camb). 2017 Apr 20;53(33):4569-4572. doi: 10.1039/c7cc00041c.
2
Photodynamic therapy and imaging based on tumor-targeted nanoprobe, polymer-conjugated zinc protoporphyrin.基于肿瘤靶向纳米探针(聚合物共轭锌原卟啉)的光动力疗法与成像
Future Sci OA. 2015 Nov 1;1(3):FSO4. doi: 10.4155/fso.15.2. eCollection 2015 Nov.
3
Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy.
Acta Naturae. 2023 Oct-Dec;15(4):100-110. doi: 10.32607/actanaturae.27331.
4
Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy.基于细菌的癌症治疗(BBCT):癌症免疫治疗的最新进展、当前挑战及未来前景
Vaccines (Basel). 2021 Dec 18;9(12):1497. doi: 10.3390/vaccines9121497.
5
Time-Resolved Studies of Ytterbium Distribution at Interfacial Surfaces of Ferritin-like Dps Protein Demonstrate Metal Uptake and Storage Pathways.铁蛋白样Dps蛋白界面表面镱分布的时间分辨研究揭示了金属摄取和储存途径。
Biomedicines. 2021 Jul 29;9(8):914. doi: 10.3390/biomedicines9080914.
6
Tailoring photosensitive ROS for advanced photodynamic therapy.定制光敏活性氧用于先进的光动力疗法。
Exp Mol Med. 2021 Apr;53(4):495-504. doi: 10.1038/s12276-021-00599-7. Epub 2021 Apr 8.
7
Recent Advances in Self-Exciting Photodynamic Therapy.自激发光动力疗法的最新进展
Front Bioeng Biotechnol. 2020 Oct 20;8:594491. doi: 10.3389/fbioe.2020.594491. eCollection 2020.
8
Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery.实验性抗癌药物 5F203 和 Phortress 的蛋白质包封:迈向精准药物递送。
Int J Nanomedicine. 2019 Dec 5;14:9525-9534. doi: 10.2147/IJN.S226293. eCollection 2019.
超越光穿透障碍:光动力疗法的策略、前景与可能性
Theranostics. 2016 Oct 23;6(13):2458-2487. doi: 10.7150/thno.16183. eCollection 2016.
4
Overcoming the Achilles' heel of photodynamic therapy.克服光动力疗法的阿喀琉斯之踵。
Chem Soc Rev. 2016 Nov 21;45(23):6488-6519. doi: 10.1039/c6cs00616g.
5
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy.活性氧生成系统应对光动力癌症治疗的挑战。
Chem Soc Rev. 2016 Nov 21;45(23):6597-6626. doi: 10.1039/c6cs00271d.
6
1001 lights: luciferins, luciferases, their mechanisms of action and applications in chemical analysis, biology and medicine.1001 种发光剂:荧光素、荧光酶、它们的作用机制及其在化学分析、生物学和医学中的应用。
Chem Soc Rev. 2016 Oct 24;45(21):6048-6077. doi: 10.1039/c6cs00296j.
7
Chemiluminescence and Bioluminescence as an Excitation Source in the Photodynamic Therapy of Cancer: A Critical Review.化学发光和生物发光作为癌症光动力疗法的激发源:批判性综述
Chemphyschem. 2016 Aug 4;17(15):2286-94. doi: 10.1002/cphc.201600270. Epub 2016 May 25.
8
Photodynamic Therapy Synergizes with Irinotecan to Overcome Compensatory Mechanisms and Improve Treatment Outcomes in Pancreatic Cancer.光动力疗法与伊立替康协同作用,以克服代偿机制并改善胰腺癌的治疗效果。
Cancer Res. 2016 Mar 1;76(5):1066-77. doi: 10.1158/0008-5472.CAN-15-0391. Epub 2015 Dec 30.
9
An Apoferritin-based Drug Delivery System for the Tyrosine Kinase Inhibitor Gefitinib.基于脱铁铁蛋白的酪氨酸激酶抑制剂吉非替尼给药系统。
Adv Healthc Mater. 2015 Dec 30;4(18):2816-21. doi: 10.1002/adhm.201500389. Epub 2015 Nov 23.
10
Photodynamic therapy via FRET following bioorthogonal click reaction in cancer cells.癌细胞中生物正交点击反应后通过荧光共振能量转移进行的光动力疗法。
Bioorg Med Chem Lett. 2016 Jan 1;26(1):145-8. doi: 10.1016/j.bmcl.2015.11.014. Epub 2015 Nov 10.